Table 2.
St Type | Mc-Targeted Material | Drug | Preparation | Response Mechanism | Function | Ref. |
---|---|---|---|---|---|---|
Endogenous stimuli-responsive En-St-Mc-DDS | ||||||
pH | PEG-Schiff base-cholesterol; Dioleoylphosphoethanolamine | TPP-PTX | Liposome | Schiff-based bond hydrolyzes at pH 6; DOPE merge with tumor lysosome membrane at pH 5.0 | Remove PEG shell; Release drug into cytoplasm; Ingest drug in Mc | [42] |
CTPP-glucolipid conjugates | Celastrol | Micelle | Celastrol is highly soluble at Mc pH 8.0 | Fast drug release at Mc; Low leakage in cytoplasm and lysosome. | [43] | |
HER-2 peptide-PEG-Schiff base-cholesterol; Dequalinium chloride vesicle | DOX | Liposome | Schiff-base bond hydrolyzes at pH 5.0–6.8 | Remove PEG-shell; Enhance drug release; Lower non-specific toxicity | [36] | |
PEG-AIE-TPP | AIE | Micelle | Hydrazone bonds of the micelles are ruptured at pH 5.3 or 6.5 | Remove PEG chain; Reduce the side effects; Increase bioavailability | [44] | |
N-(2-hydroxypropyl) methacrylamide polymer | MSN-DTX | Nanohybrid | Amide bond hydrolyzed at acidic pH; Nanohybrid dismissed in the endo/lysosomes at acidic pH | Partial presentation of MSN core and positive charge repulsion contribute to cellular internalization; Positive core leakage help endo/lysosome flee and Mc-targeting | [45] | |
Phenylboronic acid-PEG | TPP-Que | Nanoparticle | Coordination bond disrupt at acidic pH | De-PEGylation; Facilitate cellular ingestion and arrangement | [46] | |
DSPE-KLA-DMA | PTX | Liposome | Amide bond break down at pH 6.8 | Reverse charge from negative to positive; Promote cellular internalization | [47] | |
PDPA/TPGS | DOX | Micelle | Diisopropyl-substituted tertiary amino groups are protonated at pH 5.5 | Dissociate micelle; Release drug; TPGS synergistically enhance DOX effect by accumulating at Mc and lowering transmembrane potential. | [48] | |
1,5-dioctadecyl-L-glutamyl 2-histidyl-hexahydrobenzoic acid [HHG2C(18)] | – | Liposome | Reverse charge (negative to positive) at pH 6.5; Hydrolyze hexahydrobenzoic amide at pH 4.5~5.5 in endolysosome | Increase cellular uptake; Uptaken at Mc by electrostatic interaction | [49] | |
Redox | TPP-OHA-S-S-CCM | CCM | Micelle | Disulfide bonds break at a high GSH level (2~10 mM) | Release drug rapidly | [50] |
PLGA/C18-PEG2000-TPP/DLPE-S-S-mPEG4000 | PTX | Nanoparticle | The disulfide bonds break at a high GSH level (2~10 mM) | Detach PEG4000; Recover surface charges; Localize at Mc | [51] | |
Enzyme | HA/PEG | Berberine derivative | Nanodrug | Degrade HA by hyaluronidase | Expose positive charge contributes to cellular ingestion, lysosome flee and Mc location | [19] |
Non-isocyanate polyurethane-TPP | DOX | Nanocapsule | Ester linkages rupture by esterase. | Degrade polymer backbone; Release drugs site-specifically; Apply organelle-specific imaging | [52] | |
Phe-Phe-Tyr-Lys (FFYK) | TPP-peptide | Nanoscale assemblies | Dephosphorylation catalyzed by ectophosphatases | Oligomers self-assemble to form nanoassemblies on cancer cell surface | [53] | |
DNA-condensing/cell-penetrating/endosome-disruptive and mitochondria-targeting sequences | pDNA | Peptide/DNA complexes | Lysine-specific interaction | Self-organization of peptide and DNA; Structural rearrangement of complex | [37] | |
Exogenous stimuli-responsive Ex-St-Mc-DDS | ||||||
Light | IR780 | IR780 | Perfluorooctyl bromide nanoliposome | Convert energy from laser into heat through a plasmonic PTT effect; Convert oxygen into toxic ROS under irradiation at 808 nm | Mc-targeted PTT; PTT/PDT effects; Multiply imaging monitoring | [54] |
Fe3O4 | Iridium | Nanozyme | Convert energy from laser to heat through a PTT effect; Convert H2O2 to toxic hydroxyl group | Induce Mc-targeted PTT; Accelerate H2O2 catalysis | [55] | |
IR-780/DPPC/DSPC/DSPE-PEG2K-TPP | IR-780; Lonidamine | Liposome | Irradiate at 808 nm triggers IR-780 to elevate temperature to further release lonidamine from liposomes; IR-780 release ROS | Achieve Mc-targeting combinative therapy of thermosensitive chemo-, PDT/PTT | [56] | |
mPEG-CHO-PAIE-TPP | AIE | Nanoparticle | Benzoic imine bond cleaves in acidic tumor environment; AIE is photoactivated by up-converted energy upon irradiation at 980 nm | Remove PEG shell; Generate ROS in Mc and induce cell apoptosis | [57] | |
AuNS-KLA-TPP/HA | DOX | Nanoparticle | Convert energy from laser into heat through a PTT effect of gold nanostars | Achieve Mc-targeted PTT | [58] | |
TPP/Ce6/PEG-/FA-PEG-Pt@Au | Pt; Au | Nanoparticle | Convert energy from laser (808 nm) into heat through a PTT effect of Pt/Au nanoparticles | Achieve Mc-targeted multifunctional PDT/PTT strategies | [59] | |
Au-dcHSA-PEO-TAT-TPP | Au | Nanoparticle | Convert energy from laser (808 nm) into heat through a PTT effect of gold nanoparticles | Probe cellular processes (Mc dynamics and cellular vitality) | [60–63] | |
PPa-NGO-mAb | PPa | Nanodrug | Convert oxygen into toxic ROS under irradiation at 633 nm | Enhance Mc-mediated apoptosis of PDT | [64] | |
Yb/Tm/TiO2 | Yb/Tm/TiO2 | Nanoparticle | Transform NIR light to UV emission to favor TiO2 absorption; Generate intracellular ROS under irradiation | Achieve photosensitivity to NIR and produce PDT | [65] | |
TPP-coumarin- Fe3O4 | Fe3O4 | Nanoparticle | Convert energy from laser (740 nm) into heat through a PTT effect | Achieve Mc-targeted PTT | [66] | |
Cyt C aptamer-mesoporous silica-Au | Au | Nanorod | Convert energy from laser (808 nm) into heat through a PTT effect | Integrate targeting, light-triggered release, and chemo-PTT | [67] | |
SWNT-PEG | SWNT | Nanotube | Convert energy from laser (980 nm) into heat through a PTT effect | Achieve Mc-targeted PTT; Minimize adverse side effects | [68] | |
Magnetic field | PK-CP-SPION | DNA | SPION | Magnetism-guided gene delivery | Magnetism-guided deliver gene and achieve Mc-targeting therapy; Enhance therapeutic effect | [69] |
Fe3O4@mSiO2-TPP/CDs | Fe3O4 | Nanoparticle | Magnetism-guided cellular ingestion | Integrate long time imaging, Mc-targeting, and magnetism-guided cellular uptake | [70] | |
AMB-1-Cyt c aptamer | AMB-1 | Bacterial magnetic nanoparticle | Magnetism-enhanced cellular uptake | Selectively locate at Mc cytochrome C; Remotely control over subcellular elements | [71] | |
Multi-responsive St-Mc-DDS | ||||||
pH/light | Catalase@SiO2/Ce6-CTPP/DPEG | Catalase; Ce6 | Nanoparticle | Reverse surface charge (negative to slight positive) at pH 6.8; Decompose tumor endogenous H2O2 by catalase; Convert oxygen into toxic ROS under irradiation at 660 nm | Enhance cell ingestion and tumor retention; Produce O2 to enhance PDT efficacy; | [20] |
Fe3O4@DMSA/DOX | DOX; Fe3O4 | Nanoparticle | Release DOX by pH and NIR-light triggers; Convert energy from laser (808 nm) into heat through a plasmonic PTT effect | Achieve chem-PTT; Kill cell death by disrupting Mc through ROS generation | [72] | |
Redox/light/magnetic field | Fe3O4/TPP-PDA-s-s-mPEG | DOX; Fe3O4 | Nanoparticle | Disulfide bond linker is cleaved at high reduced glutathione; Convert energy from laser (808 nm) into heat through a plasmonic PTT; Disrupt π–π stacking between aromatic regions of PDA and DOX | Detach mPEG shell from nanoparticles to produce TPP; Release DOX rapidly; Achieve Mc-targeted chem-PTT | [73] |
Magnetic field/light | Fe3O4@PDA@mSiO2-TPP/-PEG | Fe3O4 | Nanoparticle | Hyperthermia and toxic ROS are induced under a single irradiation at 670 nm | Achieve Mc-targeted chem-PTT; NIR fluorescence imaging and magnetic resonance imaging | [74] |
pH/redox/temperature | MBA-PDA-PEG-PNiPMA | Pc 4 | Nanogel | Rapid intracellularly self-expand at body temperature and reduce environment; Release Pc 4 at suitable pH and redox potential; Convert oxygen into toxic ROS under irradiation at 670 nm | Control drug release at targeted sites and enhance therapeutic effect | [75] |
Redox/light | PPA | TPP-PPA | Micelle | Produce singlet oxygen by TPP-PPA/PPA upon laser irradiation | Disassemble micelle and release cargo rapidly | [76,77] |
Redox/enzyme | Glucose-polyethylene glycol (PEG)-peptide-TPP-polyamidoamine (PAMAM)-PTX | PTX | Conjugate | Detach MMP2-sensitive PEG layer from inner PAMAM and release PTX due to GSH-sensitivity | Increase tumor cellular ingestion; Acquire glucose-mediated tumor targeting; Achieve Mc location | [78] |
Note: Mc-targeting ligand is written in bold face.
Abbreviation: PSC, PEG-Schiff base-cholesterol.